ASTRAZENECA PLC (AZN)
Clinical trial NCT06634056 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-30 → 2026-06-15
Clinical trial NCT06634056 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-30 → 2026-06-15
Clinical trial NCT07623174: start date: 2026-07-01 → 2026-07-31.
Clinical trial NCT05451771 updates: 1. completion date: 2026-09-01 → 2027-09-01 2. primary completion date: 2026-09-01 → 2027-09-01
Clinical trial NCT06830798 updates: 1. completion date: 2028-11-06 → 2028-08-30 2. primary completion date: 2028-02-04 → 2027-11-30
Appointment of director - Rami Hazzan, starting from 18.6.26
FORM 6-K- Perion Launches Ask Perion, an Agentic Self-Serve Mobile App Designed to Accelerate Omnichannel Execution and Increase Efficiency
METRO AG Achieves Major Milestone in Partnership with Wipro Towards AI-Led Transformation
Neogen® Committed to Helping Ranchers, Livestock Producers, and Horse Owners Fight Against New World Screwworm
PARKE BANCORP, INC. ANNOUNCES CASH DIVIDEND
Primech Holdings Secures Approximately US$36.1 Million in New Social Services and Public Sector Integrated Facility Services Contracts